US4713249A
(en)
|
1981-11-12 |
1987-12-15 |
Schroeder Ulf |
Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
|
DE3376114D1
(en)
|
1982-12-07 |
1988-05-05 |
Kyowa Hakko Kogyo Kk |
Mitomycin analogues
|
JPS60255789A
(ja)
|
1984-06-01 |
1985-12-17 |
Kyowa Hakko Kogyo Co Ltd |
マイトマイシン誘導体,その製造法および抗腫瘍剤
|
US5266333A
(en)
|
1985-03-06 |
1993-11-30 |
American Cyanamid Company |
Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
|
EP0280741B1
(fr)
|
1986-08-29 |
1994-12-07 |
Kyowa Hakko Kogyo Kabushiki Kaisha |
Derives de mitomycine
|
USH806H
(en)
|
1987-07-16 |
1990-08-07 |
Fmc Corporation |
Herbicidal clomazone compositions and methods of use tolerant to corn and other crops
|
WO1991007418A1
(fr)
|
1989-11-13 |
1991-05-30 |
Xoma Corporation |
Anticorps a10 chimerique souris-humain avec specificite envers un antigene de cellule tumorale humaine
|
US5627165A
(en)
|
1990-06-13 |
1997-05-06 |
Drug Innovation & Design, Inc. |
Phosphorous prodrugs and therapeutic delivery systems using same
|
AU653565B2
(en)
|
1990-12-21 |
1994-10-06 |
Nikken Corporation |
Raw sewage disposal apparatus and prefab for accomodating the same
|
US6342491B1
(en)
|
1991-05-21 |
2002-01-29 |
American Home Products Corporation |
Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin
|
US6291196B1
(en)
|
1992-01-31 |
2001-09-18 |
Research Corporation Technologies, Inc. |
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
|
US7070782B1
(en)
|
1992-11-05 |
2006-07-04 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen
|
US5674977A
(en)
|
1993-02-05 |
1997-10-07 |
The Ontario Cancer Institute |
Branched synthetic peptide conjugate
|
GB9314623D0
(en)
|
1993-07-14 |
1993-08-25 |
Nordion Int Inc |
Localization and therapy with agents directed against prostate specific antigen in breast cancer
|
US6569432B1
(en)
|
1995-02-24 |
2003-05-27 |
Sloan-Kettering Institute For Cancer Research |
Prostate-specific membrane antigen and uses thereof
|
JP3538221B2
(ja)
|
1993-11-19 |
2004-06-14 |
富士写真フイルム株式会社 |
定着濃厚液およびそれを用いたハロゲン化銀写真感光材料の処理方法
|
US5417982A
(en)
|
1994-02-17 |
1995-05-23 |
Modi; Pankaj |
Controlled release of drugs or hormones in biodegradable polymer microspheres
|
US5866679A
(en)
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
US6946133B1
(en)
|
1996-03-20 |
2005-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prostate specific antigen oligo-epitope peptide
|
IL125895A
(en)
|
1996-04-01 |
2001-09-13 |
Epix Medical Inc |
Use of an image-enhancing moiety in the preparation of a bioactivated nmr or optical imaging contrast agent from a prodrug
|
AU2438497A
(en)
|
1996-04-05 |
1997-10-29 |
Johns Hopkins University, The |
A method of enriching rare cells
|
US5795877A
(en)
|
1996-12-31 |
1998-08-18 |
Guilford Pharmaceuticals Inc. |
Inhibitors of NAALADase enzyme activity
|
US5672592A
(en)
|
1996-06-17 |
1997-09-30 |
Guilford Pharmaceuticals Inc. |
Certain phosphonomethyl-pentanedioic acid derivatives thereof
|
US5863536A
(en)
|
1996-12-31 |
1999-01-26 |
Guilford Pharmaceuticals Inc. |
Phosphoramidate derivatives
|
US5902817A
(en)
|
1997-04-09 |
1999-05-11 |
Guilford Pharmaceuticals Inc. |
Certain sulfoxide and sulfone derivatives
|
US6054444A
(en)
|
1997-04-24 |
2000-04-25 |
Guilford Pharmaceuticals Inc. |
Phosphonic acid derivatives
|
US5998362A
(en)
|
1996-09-12 |
1999-12-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6368598B1
(en)
|
1996-09-16 |
2002-04-09 |
Jcrt Radiation Oncology Support Services, Inc. |
Drug complex for treatment of metastatic prostate cancer
|
US5962521A
(en)
|
1997-04-04 |
1999-10-05 |
Guilford Pharmaceuticals Inc. |
Hydroxamic acid derivatives
|
US6177404B1
(en)
|
1996-10-15 |
2001-01-23 |
Merck & Co., Inc. |
Conjugates useful in the treatment of benign prostatic hyperplasia
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6548260B1
(en)
|
1997-01-21 |
2003-04-15 |
Bayer Corporation |
Detection of PSA-α2-macroglobulin complex in a biological fluid
|
JP3981416B2
(ja)
|
1997-04-10 |
2007-09-26 |
ユニバーシティ メディカル センター ナイメーヘン |
Pca3タンパク質、pca3遺伝子、及びこれらの用途
|
US6504014B1
(en)
|
1997-05-19 |
2003-01-07 |
The John Hopkins University |
Tissue specific prodrug
|
AU7582298A
(en)
|
1997-05-19 |
1998-12-11 |
Johns Hopkins University School Of Medicine, The |
Tissue specific prodrug
|
US6127333A
(en)
|
1997-07-10 |
2000-10-03 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US20020115596A1
(en)
|
1997-10-27 |
2002-08-22 |
Merk & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
EP1036093A1
(fr)
|
1997-12-02 |
2000-09-20 |
Merck & Co., Inc. |
Conjugues utiles dans le traitement du cancer de la prostate
|
ZA9810974B
(en)
|
1997-12-02 |
1999-06-03 |
Merck & Co Inc |
Conjugates useful in the treatment of prostate cancer
|
US20040081659A1
(en)
|
1997-12-02 |
2004-04-29 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
CA2322975A1
(fr)
|
1998-03-03 |
1999-09-10 |
Mosaic Technologies |
Procedes de purification et de detection par electrophorese d'affinite reversible
|
US20020103136A1
(en)
|
1998-03-05 |
2002-08-01 |
Dong-Mei Feng |
Conjugates useful in the treatment of prostate cancer
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
US6093382A
(en)
|
1998-05-16 |
2000-07-25 |
Bracco Research Usa Inc. |
Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
|
FR2778820B1
(fr)
|
1998-05-20 |
2000-07-28 |
Rhone Poulenc Agrochimie |
Melanges herbicides a base d'aclonifen et de clomazone
|
ATE437947T1
(de)
|
1998-06-01 |
2009-08-15 |
Agensys Inc |
Serpentintransmembranantigene exprimiert in menschlichem krebs und deren verwendungen
|
US6833438B1
(en)
|
1999-06-01 |
2004-12-21 |
Agensys, Inc. |
Serpentine transmembrane antigens expressed in human cancers and uses thereof
|
US6518033B1
(en)
|
1998-08-05 |
2003-02-11 |
The Research Foundation Of State University Of New York |
Method of detecting the presence of CD155 for diagnosis of cancer and to determine treatment
|
US20070020327A1
(en)
|
1998-11-10 |
2007-01-25 |
John Fikes |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
US6174858B1
(en)
|
1998-11-17 |
2001-01-16 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6602274B1
(en)
|
1999-01-15 |
2003-08-05 |
Light Sciences Corporation |
Targeted transcutaneous cancer therapy
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
AU4063600A
(en)
|
1999-04-05 |
2000-10-23 |
Merck & Co., Inc. |
A method of treating cancer
|
ATE298343T1
(de)
|
1999-04-28 |
2005-07-15 |
Univ Georgetown |
Ligande für metabotropische glutamat-rezeptoren
|
US6528499B1
(en)
|
2000-04-27 |
2003-03-04 |
Georgetown University |
Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
|
AUPQ014799A0
(en)
|
1999-05-04 |
1999-05-27 |
Access Pharmaceuticals Australia Pty Limited |
Amplification of folate-mediated targeting to tumor cells using polymers
|
US7166573B1
(en)
|
1999-05-28 |
2007-01-23 |
Ludwig Institute For Cancer Research |
Breast, gastric and prostate cancer associated antigens and uses therefor
|
US20040146516A1
(en)
|
1999-06-17 |
2004-07-29 |
Utah Ventures Ii L.P. |
Lumen-exposed molecules and methods for targeted delivery
|
PL354186A1
(en)
|
1999-07-13 |
2003-12-29 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, asTHE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES HEALTH AND HUMAN SERVICES |
T-cell receptor gamma alternate reading frame protein, (tarp) and uses thereof
|
AU6620300A
(en)
|
1999-08-03 |
2001-02-19 |
Ohio State University, The |
Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
|
US7361338B2
(en)
|
1999-10-05 |
2008-04-22 |
Agensys, Inc. |
Methods to inhibit growth of prostate cancer cells
|
US6692724B1
(en)
|
1999-10-25 |
2004-02-17 |
Board Of Regents, The University Of Texas System |
Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
|
CA2387901A1
(fr)
|
1999-10-27 |
2001-05-03 |
Merck & Co., Inc. |
Sel d'un conjugue utile pour traiter le cancer de la prostate
|
US6428785B1
(en)
|
1999-10-28 |
2002-08-06 |
Immunolytics Inc. |
Method and composition for treating prostate cancer
|
US6511676B1
(en)
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
CA2391534A1
(fr)
|
1999-11-15 |
2001-05-25 |
Drug Innovation & Design, Inc. |
Ciblage cellulaire selectif: vecteurs d'administration multifonctionnels
|
NZ521898A
(en)
|
2000-03-31 |
2004-11-26 |
Purdue Research Foundation |
Use of a ligand-immunogen conjugate such as folate-FITC for enhancing an endogenous immune response
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
WO2002033116A2
(fr)
|
2000-10-16 |
2002-04-25 |
Gilead Sciences, Inc. |
Ligands d'acides nucleiques de l'antigene membranaire prostatique specifique
|
US20020132983A1
(en)
|
2000-11-30 |
2002-09-19 |
Junghans Richard P. |
Antibodies as chimeric effector cell receptors against tumor antigens
|
AU2002239403A1
(en)
|
2000-12-01 |
2002-06-11 |
The Johns Hopkins University |
Tissue specific prodrugs
|
AU2002249935A1
(en)
|
2001-01-08 |
2002-08-19 |
Neorx Corporation |
Radioactively labelled conjugates of phosphonates
|
ATE337011T1
(de)
|
2001-02-07 |
2006-09-15 |
Beth Israel Hospital |
Modifizierte psma-liganden und deren verwendung
|
WO2002074345A2
(fr)
|
2001-03-16 |
2002-09-26 |
Johns Hopkins University School Of Medicine |
Modulation des réponses immunitaires systémiques par transplantation de cellules souches hématopoïétiques transduites avec des gènes codant des antigènes et des molécules de régulation cellulaire présentant des antigènes
|
DK1381611T3
(da)
|
2001-03-21 |
2005-10-24 |
Molteni & C |
Metalsubstituerede ikke-centrosymmetriske phthalocyaninanaloger, fremstilling heraf og anvendelse i fotodynamisk terapi samt in vivo diagnostik
|
ES2622468T3
(es)
|
2001-03-29 |
2017-07-06 |
Synergy Pharmaceuticals, Inc. |
Agonistas del receptor de guanilato ciclasa para el tratamiento de inflamación tisular y carcinogénesis
|
EP1389209B1
(fr)
|
2001-04-24 |
2009-04-08 |
Purdue Research Foundation |
Mimetiques de folate et ses conjugues se liant au recepteur de folate
|
KR20040015234A
(ko)
|
2001-05-02 |
2004-02-18 |
펄듀 리서치 파운데이션 |
대식세포 매개된 질환의 치료와 진단
|
US20040092890A1
(en)
|
2001-05-10 |
2004-05-13 |
Ash Stephen R. |
Catheter lock solution including a photo-oxidant
|
US7109165B2
(en)
|
2001-05-18 |
2006-09-19 |
Sirna Therapeutics, Inc. |
Conjugates and compositions for cellular delivery
|
MXPA03010804A
(es)
|
2001-06-01 |
2004-11-22 |
Cornell Res Foundation Inc |
Anticuerpos modificados para antigeno de membrana especifico de la prostata y usos de los mismos.
|
US7514078B2
(en)
|
2001-06-01 |
2009-04-07 |
Cornell Research Foundation, Inc. |
Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
|
US7666414B2
(en)
|
2001-06-01 |
2010-02-23 |
Cornell Research Foundation, Inc. |
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
|
US20040018203A1
(en)
|
2001-06-08 |
2004-01-29 |
Ira Pastan |
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates
|
WO2003000117A2
(fr)
|
2001-06-21 |
2003-01-03 |
Glycotech Corporation |
Detection et traitement du cancer de la prostate
|
EP1409017A4
(fr)
|
2001-06-25 |
2006-05-24 |
Drug Innovation & Design Inc |
Ciblage cellulaire faisant appel a la reconnaissance des formes exponentielle, compositions, procedes et applications anticancereuses
|
US6596755B2
(en)
|
2001-07-02 |
2003-07-22 |
Dabur Research Foundation |
Oral formulation of methylglyoxal and its imino acid conjugates for human use
|
WO2003004469A1
(fr)
|
2001-07-02 |
2003-01-16 |
Dabur Research Foundation |
Action anticancereuse de conjugues iminoacides de methylglyoxal
|
US7893223B2
(en)
|
2001-07-17 |
2011-02-22 |
Bracco Imaging S.P.A. |
Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
|
ES2388170T3
(es)
|
2001-08-24 |
2012-10-09 |
Uvic Industry Partnerships Inc. |
Proaerolisina que contiene secuencias de activación de proteasa y métodos de uso para el tratamiento del cáncer de próstata
|
US20030049203A1
(en)
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
IL159422A0
(en)
|
2001-09-20 |
2004-06-01 |
Cornell Res Foundation Inc |
Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen
|
US20030232760A1
(en)
|
2001-09-21 |
2003-12-18 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
WO2003028634A2
(fr)
|
2001-09-28 |
2003-04-10 |
Purdue Research Foundation |
Methode de traitement utilisant des conjugues ligand-immunogene
|
US20030215456A1
(en)
|
2001-10-02 |
2003-11-20 |
Sui-Long Yao |
Method of treating cancer
|
US20030133927A1
(en)
|
2001-10-10 |
2003-07-17 |
Defeo-Jones Deborah |
Conjugates useful in the treatment of prostate cancer
|
US20040058857A1
(en)
|
2001-11-29 |
2004-03-25 |
Siu-Long Yao |
Method of treating cancer
|
US20070031438A1
(en)
|
2001-12-10 |
2007-02-08 |
Junghans Richard P |
Antibodies as chimeric effector cell receptors against tumor antigens
|
AU2002364202A1
(en)
|
2001-12-21 |
2003-07-30 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt |
Novel metastasis suppressor gene on human chromosome 8
|
PT1472541E
(pt)
|
2002-01-10 |
2009-12-21 |
Univ Johns Hopkins |
Agentes de imagiologia e métodos de imagiologia de naaladase de psma
|
WO2003065787A2
(fr)
|
2002-02-06 |
2003-08-14 |
Johns Hopkins University School Of Medicine |
Procedes et compositions de ciblage de reponse immunitaire systemique contre un organe ou un tissu specifique
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
US8491896B2
(en)
|
2002-06-14 |
2013-07-23 |
Immunomedics, Inc. |
Anti-pancreatic cancer antibodies
|
US7344700B2
(en)
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
US20170281791A1
(en)
|
2002-03-01 |
2017-10-05 |
Immunomedics, Inc. |
Anti-trop-2 antibody-drug conjugates and uses thereof
|
US9745380B2
(en)
|
2002-03-01 |
2017-08-29 |
Immunomedics, Inc. |
RS7 antibodies
|
US9770517B2
(en)
|
2002-03-01 |
2017-09-26 |
Immunomedics, Inc. |
Anti-Trop-2 antibody-drug conjugates and uses thereof
|
EP1483295B1
(fr)
|
2002-03-01 |
2008-12-10 |
Immunomedics, Inc. |
Anticorps rs7
|
CN1650033A
(zh)
|
2002-03-07 |
2005-08-03 |
约翰霍普金斯大学医学院 |
针对与癌症相关的表观遗传学沉默基因的基因组筛选
|
US7534580B2
(en)
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
CN101648028B
(zh)
|
2002-05-06 |
2012-11-21 |
恩多塞特公司 |
维生素-定向的显象剂
|
JP4814520B2
(ja)
|
2002-05-15 |
2011-11-16 |
エンドサイト,インコーポレイテッド |
ビタミン−マイトマイシン結合体
|
BR0311799A
(pt)
|
2002-06-14 |
2005-05-10 |
Immunomedics Inc |
Anticorpo monoclonal hpam4
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
AR040956A1
(es)
|
2002-07-31 |
2005-04-27 |
Schering Ag |
Nuevos conjugados de efectores, procedimientos para su preparacion y su uso farmaceutico
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
US7749968B2
(en)
|
2002-08-05 |
2010-07-06 |
The Johns Hopkins University |
Peptides for targeting the prostate specific membrane antigen
|
US7662795B2
(en)
|
2002-08-08 |
2010-02-16 |
The Johns Hopkins University |
Enhancement of adenoviral oncolytic activity by modification of the E1A gene product
|
US8487128B2
(en)
|
2002-11-26 |
2013-07-16 |
Chs Pharma, Inc. |
Protection of normal cells
|
US8420086B2
(en)
|
2002-12-13 |
2013-04-16 |
Immunomedics, Inc. |
Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
|
EP1572242B1
(fr)
|
2002-12-13 |
2014-04-16 |
Immunomedics, Inc. |
Immunoconjugues comprenant une liaison intracellulaire clivable
|
US7166691B2
(en)
|
2002-12-20 |
2007-01-23 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Saposin C and receptors as targets for treatment of benign and malignant disorders
|
AU2003303374A1
(en)
|
2002-12-20 |
2004-07-22 |
The Johns Hopkins University |
Treatment of metastatic cancer with the b-subunit of shiga toxin
|
US7226577B2
(en)
|
2003-01-13 |
2007-06-05 |
Bracco Imaging, S. P. A. |
Gastrin releasing peptide compounds
|
US20080008649A1
(en)
*
|
2003-01-13 |
2008-01-10 |
Bracco Imaging S.P.A. |
Gastrin Releasing Peptide Compounds
|
EP2517729A3
(fr)
|
2003-01-27 |
2013-01-02 |
Endocyte, Inc. |
Conjugués d'administration de médicaments à liaison au récepteur de vitamines
|
CA2514419A1
(fr)
|
2003-01-28 |
2004-08-12 |
Proscan Rx Pharma Inc. |
Diagnostic et traitement du cancer de la prostate
|
EP1444990A1
(fr)
|
2003-02-07 |
2004-08-11 |
Amersham plc |
Compositions ameliorées des radiométaux complexés
|
US7160885B2
(en)
|
2003-02-10 |
2007-01-09 |
Cgi Pharmaceuticals, Inc. |
Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity
|
EP1603392A2
(fr)
|
2003-03-07 |
2005-12-14 |
The University Of Toledo |
Derives hybrides de palitaxel
|
US7638122B2
(en)
|
2003-03-07 |
2009-12-29 |
University Of South Florida |
Stat3 antagonists and their use as vaccines against cancer
|
US20070179100A1
(en)
|
2003-04-09 |
2007-08-02 |
Muthiah Manoharan |
Protected monomers
|
EP2666858A1
(fr)
|
2003-04-17 |
2013-11-27 |
Alnylam Pharmaceuticals Inc. |
Agents iARN modifiés
|
WO2004096120A2
(fr)
|
2003-05-01 |
2004-11-11 |
Nst Neurosurvival Technologies Ltd. |
Composes se liant selectivement a des membranes de cellules apoptotiques
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
EP1633773A4
(fr)
|
2003-06-13 |
2010-10-20 |
Immunomedics Inc |
Peptides d'acides amines d
|
US7232805B2
(en)
|
2003-09-10 |
2007-06-19 |
Inflabloc Pharmaceuticals, Inc. |
Cobalamin conjugates for anti-tumor therapy
|
WO2005051315A2
(fr)
|
2003-11-24 |
2005-06-09 |
The Regents Of The University Of California |
Lieurs a clivage selectif pour de conjugues radio-immunologiques pour l'imagerie et la therapie du cancer
|
FR2864546A1
(fr)
|
2003-12-24 |
2005-07-01 |
Assist Publ Hopitaux De Paris |
Methode d'identification et de preparation de lymphocytes t regulateurs/suppresseurs, compositions et utilisations
|
US20080089892A1
(en)
|
2004-01-12 |
2008-04-17 |
Eli Lilly And Co. |
Fc Region Variants
|
US8586932B2
(en)
|
2004-11-09 |
2013-11-19 |
Spectrum Dynamics Llc |
System and method for radioactive emission measurement
|
WO2006075333A2
(fr)
|
2005-01-13 |
2006-07-20 |
Spectrum Dynamics Llc |
Reconstruction et analyse d'image pluridimensionnelle pour diagnostic par systeme expert
|
WO2006051531A2
(fr)
|
2004-11-09 |
2006-05-18 |
Spectrum Dynamics Llc |
Radio-imagerie
|
WO2007010534A2
(fr)
|
2005-07-19 |
2007-01-25 |
Spectrum Dynamics Llc |
Protocoles d'imagerie
|
DE102004004787A1
(de)
|
2004-01-30 |
2005-08-18 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
US7375078B2
(en)
|
2004-02-23 |
2008-05-20 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
EP1610818A4
(fr)
|
2004-03-03 |
2007-09-19 |
Millennium Pharm Inc |
Anticorps modifies diriges contre un antigene membranaire specifique de la prostate
|
WO2005085292A2
(fr)
|
2004-03-03 |
2005-09-15 |
Biomerieux |
Procede de detection de la forme libre activable du psa et son utilisation pour le diagnostic des pathologies benignes de la prostate et de l'adenocarcinome de la prostate
|
ES2311895T3
(es)
|
2004-03-15 |
2009-02-16 |
F. Hoffmann-La Roche Ag |
El uso de los peptidos tipo bnp y de los peptidos tipo anf para evaluar el riesgo de padecer una complicacion cardio-vascular como frecuencia de sobrecarga del volumen.
|
WO2005111238A2
(fr)
|
2004-04-19 |
2005-11-24 |
Archemix Corporation |
Delivrance intracellulaire oligonucleotides therapeutiques mediee par des aptameres
|
CA2606138A1
(fr)
|
2004-04-19 |
2005-10-27 |
Proscan Rx Pharma |
Diagnostic et traitement du cancer de la prostate
|
WO2005112919A2
(fr)
|
2004-05-19 |
2005-12-01 |
Medarex, Inc. |
Bras de liaison chimiques et conjugues associes
|
RU2402548C2
(ru)
|
2004-05-19 |
2010-10-27 |
Медарекс, Инк. |
Химические линкеры и их конъюгаты
|
US20080008719A1
(en)
|
2004-07-10 |
2008-01-10 |
Bowdish Katherine S |
Methods and compositions for the treatment of prostate cancer
|
EP1789391B1
(fr)
|
2004-07-23 |
2017-06-28 |
Endocyte, Inc. |
Groupes de liaison bivalents et conjugués de ceux-ci
|
US20060148741A1
(en)
|
2004-07-26 |
2006-07-06 |
Government Of The Usa, Represented By The Secretary, Department Of Health And Human Services |
Metastasis suppressor gene on human chromosome 8 and its use in the diagnosis, prognosis and treatment of cancer
|
CN101001873B
(zh)
|
2004-08-04 |
2013-03-13 |
曼璀克生物科技有限责任公司 |
Fc区变体
|
US20060045883A1
(en)
|
2004-08-26 |
2006-03-02 |
Jeffrey Molldrem |
Anti-cancer vaccines
|
WO2006024160A1
(fr)
|
2004-08-30 |
2006-03-09 |
Neuromed Pharmaceuticals Ltd. |
Dérivés de l'urée agissant comme agents bloquant un canal de calcium
|
US8194660B2
(en)
|
2004-09-09 |
2012-06-05 |
Amx Llc |
System, method, and computer-readable medium for dynamic device discovery for servers binding to multiple masters
|
US7713944B2
(en)
|
2004-10-13 |
2010-05-11 |
Isis Pharmaceuticals, Inc. |
Oligomers comprising activated disulfides which bind to plasma proteins and their use for delivery to cells
|
US7638525B2
(en)
|
2004-10-27 |
2009-12-29 |
Janssen Pharmaceutica N.V. |
Trisubstituted thiophenes as progesterone receptor modulators
|
US8000773B2
(en)
|
2004-11-09 |
2011-08-16 |
Spectrum Dynamics Llc |
Radioimaging
|
US20060140871A1
(en)
|
2004-11-30 |
2006-06-29 |
Sillerud Laurel O |
Magnetic resonance imaging of prostate cancer
|
US20060155021A1
(en)
|
2005-01-13 |
2006-07-13 |
Lenges Christian P |
Coating compositions containing rheology control agents
|
US7741510B2
(en)
|
2005-01-13 |
2010-06-22 |
E. I. Du Pont De Nemours And Company |
Rheology control agents
|
US20090258002A1
(en)
|
2005-02-01 |
2009-10-15 |
Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers for Tissue Status
|
WO2006093991A1
(fr)
|
2005-03-02 |
2006-09-08 |
The Cleveland Clinic Foundation |
Composes se liant a l'antigene membranaire specifique de la prostate (psma) et utilisations associees
|
WO2006096754A2
(fr)
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Aptameres stabilises d'apsm et leur utilisation comme agents therapeutiques contre le cancer de la prostate
|
US8088908B2
(en)
|
2005-05-10 |
2012-01-03 |
City Of Hope |
Humanized anti-prostate stem cell antigen monoclonal antibody
|
KR101068612B1
(ko)
|
2005-05-24 |
2011-09-30 |
휴마시스 주식회사 |
유사구조 단백질 비율 측정을 이용한 진단장치
|
DK1891093T3
(da)
|
2005-06-14 |
2011-07-11 |
Protox Therapeutics Inc |
Fremgangsmåde til behandling eller forebyggelse af benign prostatahyperplasi ved anvendelse af modificerede poredannende proteiner
|
PL1912677T3
(pl)
|
2005-06-20 |
2014-03-31 |
Psma Dev Company L L C |
Koniugaty przeciwciało PSMA-lek
|
US20070009434A1
(en)
|
2005-07-05 |
2007-01-11 |
Low Philip S |
Imaging and therapeutic method using monocytes
|
US20070010014A1
(en)
|
2005-07-06 |
2007-01-11 |
General Electric Company |
Compositions and methods for enhanced delivery to target sites
|
JP2009504786A
(ja)
|
2005-08-19 |
2009-02-05 |
シーラス コーポレイション |
リステリア属誘導型免疫漸増および活性化、ならびにその使用方法
|
CN103893778A
(zh)
|
2005-08-19 |
2014-07-02 |
恩多塞特公司 |
多药物配体缀合物
|
JP2009504783A
(ja)
|
2005-08-19 |
2009-02-05 |
エンドサイト,インコーポレイテッド |
ビンカアルカロイド、類似体および誘導体のリガンド結合体
|
WO2007033215A2
(fr)
|
2005-09-12 |
2007-03-22 |
The Johns Hopkins University |
Compositions ayant une activite antiangiogenique et leurs utilisations
|
EP1940841B9
(fr)
|
2005-10-07 |
2017-04-19 |
Guerbet |
Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
|
CA2670355A1
(fr)
|
2005-11-21 |
2008-04-24 |
Medivas, Llc |
Particules polymeriques pour administration de macromolecules et procedes d'utilisation
|
JP5199880B2
(ja)
|
2005-11-23 |
2013-05-15 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
分子コンジュゲート
|
WO2007087131A2
(fr)
|
2006-01-05 |
2007-08-02 |
The Johns Hopkins University |
Promedicaments peptides
|
WO2007081751A2
(fr)
|
2006-01-05 |
2007-07-19 |
The Johns Hopkins University |
Compositions et procedes destines au traitement du cancer
|
US7635682B2
(en)
|
2006-01-06 |
2009-12-22 |
Genspera, Inc. |
Tumor activated prodrugs
|
RU2008135318A
(ru)
|
2006-02-01 |
2010-03-10 |
Дзе Джонс Хопкинс Юниверсити (Us) |
Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии неопластических или инфекционных заболеваний
|
EP1999136B1
(fr)
|
2006-03-14 |
2012-10-24 |
Cancer Targeted Technology LLC |
Inhibiteurs peptidomimétiques du psma, composés les comprenant, et procédés d'utilisation
|
ATE509033T1
(de)
|
2006-03-20 |
2011-05-15 |
Univ California |
Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting
|
US20070225213A1
(en)
|
2006-03-23 |
2007-09-27 |
Kosak Matthew K |
Nucleic acid carriers for delivery of therapeutic agents
|
US20140314864A1
(en)
|
2006-03-31 |
2014-10-23 |
Massachusetts Institute Of Technology |
System for Targeted Delivery of Therapeutic Agents
|
JP2009534309A
(ja)
|
2006-03-31 |
2009-09-24 |
マサチューセッツ インスティテュート オブ テクノロジー |
治療剤の標的化送達のためのシステム
|
US7842280B2
(en)
|
2006-09-06 |
2010-11-30 |
Case Western Reserve University |
Flexibly labeling peptides
|
US8685752B2
(en)
|
2006-11-03 |
2014-04-01 |
Purdue Research Foundation |
Ex vivo flow cytometry method and device
|
PT3699162T
(pt)
|
2006-11-08 |
2022-10-11 |
Molecular Insight Pharm Inc |
Heterodímeros de ácido glutâmico
|
US9387344B2
(en)
|
2006-11-21 |
2016-07-12 |
The Johns Hopkins University |
Methods for determining absorbed dose information
|
EP2500015A1
(fr)
|
2006-12-05 |
2012-09-19 |
Landec Corporation |
Administration de médicaments
|
US8507434B2
(en)
|
2007-01-03 |
2013-08-13 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
CN103372221B
(zh)
|
2007-01-11 |
2016-08-24 |
免疫医学股份有限公司 |
用于蛋白质、肽和其他分子的改进的f-18标记的方法和组合物
|
AU2007345648A1
(en)
|
2007-01-26 |
2008-08-07 |
City Of Hope |
Methods and compositions for the treatment of cancer or other diseases
|
US8586595B2
(en)
|
2007-02-07 |
2013-11-19 |
Purdue Research Foundation |
Positron emission tomography imaging method
|
WO2008101231A2
(fr)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Procédés et compositions de traitement et de diagnostic d'une maladie rénale
|
EP2139523B1
(fr)
|
2007-03-14 |
2014-10-22 |
Endocyte, Inc. |
Conjugés de folate et de tubulysine pour le ciblage d'agents actifs
|
PT2136788E
(pt)
|
2007-03-30 |
2012-02-03 |
Bind Biosciences Inc |
Direccionamento a células de cancro utilizando nanopartículas
|
WO2008124197A1
(fr)
|
2007-04-10 |
2008-10-16 |
The Johns Hopkins University |
Imagerie et thérapie des tumeurs associées à un virus
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
CA2926573C
(fr)
*
|
2007-06-26 |
2018-08-28 |
The Johns Hopkins University |
Inhibiteurs marque de l'antigene membranaire specifique de la prostate (psma), evaluation biologique, et utilisation en tant qu'agents d'imagerie
|
GB0723246D0
(en)
|
2007-07-03 |
2008-01-09 |
Barton Michelle |
p53 modulator
|
AU2008293885A1
(en)
|
2007-07-13 |
2009-03-05 |
The John Hopkins University |
B7-DC variants
|
CA2695385A1
(fr)
|
2007-07-31 |
2009-02-05 |
Atul Bedi |
Conjugue d'acide nucleique de polypeptide destine a l'immunoprophylaxie ou a l'immunotherapie des troubles neoplasiques ou infectieux
|
WO2009021178A1
(fr)
|
2007-08-08 |
2009-02-12 |
Chemimage Corporation |
Classification des maladies basée sur le spectre raman par différence
|
EP3388086B1
(fr)
|
2007-08-17 |
2020-10-07 |
Purdue Research Foundation |
Conjugués comprenant un ligand du psma et un lieur et procédés pour leur utilisation
|
WO2009026274A1
(fr)
|
2007-08-22 |
2009-02-26 |
Medarex, Inc. |
Attachement spécifique d'un site de médicaments ou autres agents à des anticorps synthétisés par génie génétique avec des extensions c-terminales
|
WO2009033161A1
(fr)
|
2007-09-07 |
2009-03-12 |
The John Hopkins University |
Rôle d'agonistes et d'antagonistes du récepteur de l'adénosine dans la modulation de réponses cellulaires
|
WO2009035942A1
(fr)
|
2007-09-13 |
2009-03-19 |
Chemimage Corporation |
Distinction entre un oncocytome rénal et un carcinome de cellule rénale chromophobe à l'aide de l'imagerie moléculaire raman
|
AU2008316835B2
(en)
|
2007-10-25 |
2015-07-16 |
Endocyte, Inc. |
Tubulysins and processes for preparing
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
US9422234B2
(en)
|
2007-11-30 |
2016-08-23 |
The Johns Hopkins University |
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
|
CA2708171C
(fr)
|
2007-12-04 |
2018-02-27 |
Alnylam Pharmaceuticals, Inc. |
Conjugues du folate
|
US20090180951A1
(en)
|
2007-12-12 |
2009-07-16 |
Molecular Insight Pharmaceuticals, Inc. |
Inhibitors of integrin vla-4
|
BRPI0906797A2
(pt)
|
2008-01-09 |
2015-07-14 |
Molecular Insight Pharm Inc |
Inibidores de anidrase carbônica ix
|
US8565945B2
(en)
|
2008-01-17 |
2013-10-22 |
Lockheed Martin Corporation |
Method for managing vital train movements
|
CA2720571A1
(fr)
|
2008-04-04 |
2009-10-08 |
Molecular Insight Pharmaceuticals, Inc. |
Systeme d'infusion de traitement radiomarque, appareil et ses procedes d'utilisation
|
WO2010005721A2
(fr)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences, Inc. |
Nanoparticules polymères pharmacologiquement chargées et leurs méthodes de fabrication et d’utilisation
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
WO2009137807A2
(fr)
|
2008-05-08 |
2009-11-12 |
Asuragen, Inc. |
Compositions et procédés liés à la modulation de miarn de néovascularisation ou d’angiogenèse
|
US8852630B2
(en)
|
2008-05-13 |
2014-10-07 |
Yale University |
Chimeric small molecules for the recruitment of antibodies to cancer cells
|
PT2291659E
(pt)
|
2008-05-13 |
2016-01-22 |
Univ Yale |
Moléculas quiméricas pequenas para o recrutamento de anticorpos contra células cancerosas
|
US20110305768A1
(en)
|
2008-07-01 |
2011-12-15 |
The Johns Hopkins University |
Quick-dissolving oral thin film for targeted delivery of therapeutic agents
|
CN113563262A
(zh)
|
2008-08-01 |
2021-10-29 |
约翰.霍普金斯大学 |
Psma-结合剂及其用途
|
US8685937B2
(en)
|
2008-08-09 |
2014-04-01 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
WO2010019963A2
(fr)
|
2008-08-15 |
2010-02-18 |
Georgetown University |
Canaux sodiques, maladie, et dosages et compositions apparentées
|
EP2326350B1
(fr)
|
2008-09-08 |
2013-09-04 |
Psma Development Company, L.L.C. |
Composés pour tuer des cellules cancéreuses exprimant psma et résistantes au taxane
|
EP2166021A1
(fr)
|
2008-09-16 |
2010-03-24 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux pour le traitement du cancer
|
JP5675619B2
(ja)
|
2008-09-17 |
2015-02-25 |
エンドサイト, インク.Endocyte, Inc. |
葉酸拮抗薬の葉酸受容体結合性コンジュゲート
|
WO2010045598A2
(fr)
|
2008-10-17 |
2010-04-22 |
Purdue Research Foundation |
Conjugués lieur-ligand de liaison au psma et procédés d'utilisation
|
WO2010065906A2
(fr)
|
2008-12-05 |
2010-06-10 |
Molecular Insight Pharmaceuticals, Inc. |
Produits radiopharmaceutiques spécifiques de ca-ix pour le traitement et l'imagerie de cancer
|
RU2539565C2
(ru)
|
2008-12-05 |
2015-01-20 |
Моликьюлар Инсайт Фармасьютикалз, Инк. |
Са-ix специфические радиофармпрепараты для лечения и визуалазиции злокачественных опухолей
|
EP2706057B1
(fr)
|
2008-12-05 |
2016-04-20 |
Molecular Insight Pharmaceuticals, Inc. |
Dérivés de bis(imidazolyl) et complexes de radionucleides
|
EP3470087A1
(fr)
|
2009-02-13 |
2019-04-17 |
Immunomedics, Inc. |
Compositions lyophilisées d'immunoconjugués comportant une liaison clivable au niveau intracellulaire
|
EP3495000A1
(fr)
|
2009-02-17 |
2019-06-12 |
Cornell Research Foundation, Inc. |
Procédés et kits pour le diagnostic du cancer et la prédiction d'une valeur thérapeutique
|
EP2403539A2
(fr)
|
2009-03-02 |
2012-01-11 |
Massachusetts Institute of Technology |
Méthodes et systèmes de traitement et/ou de diagnostic
|
WO2010107909A2
(fr)
|
2009-03-17 |
2010-09-23 |
The Johns Hopkins University |
Méthodes et compositions pour le dépistage du cancer
|
US10717750B2
(en)
|
2009-03-19 |
2020-07-21 |
The Johns Hopkins University |
68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents
|
US9056841B2
(en)
|
2009-03-19 |
2015-06-16 |
The Johns Hopkins University |
PSMA-targeting compounds and uses thereof
|
US9757084B2
(en)
|
2011-12-22 |
2017-09-12 |
The Johns Hopkins University |
Method and system for administering radiopharmaceutical therapy (RPT)
|
US20120183847A1
(en)
|
2009-05-19 |
2012-07-19 |
Aic Blab |
Composite current collector and methods therefor
|
BR112012000209B8
(pt)
|
2009-06-15 |
2021-07-27 |
Molecular Insight Pharm Inc |
heterodímeros de ácido glutâmico e seus processos de preparação
|
US20120128587A1
(en)
|
2009-07-31 |
2012-05-24 |
Endocyte, Inc. |
Folate-targeted diagnostics and treatment
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
WO2011031517A1
(fr)
|
2009-08-27 |
2011-03-17 |
Nuclea Biotechnologies, LLC |
Procédé et dosage pour déterminer l'expression de fas
|
MX354143B
(es)
|
2009-12-02 |
2018-02-14 |
Imaginab Inc |
Minicuerpos j591 y diacuerpos-cys para apuntar con especificidad de objetivo a un antígeno de membrana específico para próstata de humano (psma) y métodos para su uso.
|
TR201906255T4
(tr)
|
2009-12-11 |
2019-05-21 |
Pfizer |
Terapötik partiküllerin liyofilize edilmesine yönelik stabil formülasyonlar.
|
EP2531029B1
(fr)
|
2010-02-04 |
2016-10-19 |
Radius Health, Inc. |
Modulateurs sélectifs du récepteur des androgènes
|
CA2790577A1
(fr)
|
2010-02-25 |
2011-09-01 |
Purdue Research Foundation |
Conjugues ligand de liaison a un antigene de membrane specifique a la prostate (psma) lieur et procedes d'utilisation associes
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
WO2011109422A2
(fr)
|
2010-03-02 |
2011-09-09 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Compositions et procédés de traitement du cancer
|
JP2010159277A
(ja)
|
2010-03-04 |
2010-07-22 |
Sumitomo Chemical Co Ltd |
有害生物防除組成物及び有害生物の防除方法
|
EP2371864A1
(fr)
|
2010-03-23 |
2011-10-05 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux pour le traitement du cancer
|
WO2011127210A1
(fr)
|
2010-04-06 |
2011-10-13 |
Massachusetts Institute Of Technology |
Administration ciblée d'acides nucléiques
|
US20130028917A1
(en)
|
2010-04-15 |
2013-01-31 |
Spirogen Developments Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
US8858509B2
(en)
|
2010-05-05 |
2014-10-14 |
Safety Syringes, Inc. |
Needle based helical coil safety device
|
CN101863924B
(zh)
|
2010-05-17 |
2012-06-27 |
北京师范大学 |
99mTc标记肼基烟酰胺基-二氧辛酰-叶酸配合物及制备方法
|
CN103118678A
(zh)
|
2010-07-16 |
2013-05-22 |
约翰斯·霍普金斯大学 |
用于癌症免疫治疗的方法和组合物
|
US9029340B2
(en)
|
2010-07-22 |
2015-05-12 |
The Johns Hopkins University |
Radiation sensitization agents for prostate cancer
|
US9580474B2
(en)
|
2010-09-08 |
2017-02-28 |
The Johns Hopkins University |
Polyionic papilloma virus-like particle (VLP) vaccines
|
KR101236142B1
(ko)
|
2010-09-30 |
2013-02-21 |
경북대학교 산학협력단 |
가돌리늄 착물을 함유하는 mri조영제
|
EP2648766B1
(fr)
|
2010-12-06 |
2018-04-18 |
Molecular Insight Pharmaceuticals, Inc. |
Dendrimères ciblés sur la psma
|
WO2012135592A2
(fr)
|
2011-03-31 |
2012-10-04 |
The Johns Hopkins University |
Agents d'imagerie théranostique et leurs procédés d'utilisation
|
CN106632677B
(zh)
|
2011-04-01 |
2021-10-26 |
纪念斯隆-凯特琳癌症中心 |
对hla-a2呈递的wt1肽特异的t细胞受体样抗体
|
BR112013026905B1
(pt)
|
2011-04-21 |
2021-09-14 |
Orion Corporation |
Compostos de carboxamida moduladora do receptor de andrógeno e seu uso no tratamento e prevenção de câncer de próstata, bem como composições farmacêuticas compreendendo os ditos compostos
|
US9180214B1
(en)
|
2011-04-22 |
2015-11-10 |
Stc.Unm |
Gonadotropin-releasing hormone receptor-targeting peptides and their use to treat and diagnose cancer
|
WO2012154511A2
(fr)
|
2011-05-06 |
2012-11-15 |
The Johns Hopkins University |
Procédé et dispositif de prélèvement statistique de tissu au moyen de microdispositifs
|
US20140308363A1
(en)
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
CN107325127B
(zh)
*
|
2011-06-15 |
2020-09-01 |
癌靶技术有限责任公司 |
螯合的psma抑制剂
|
CA2844151C
(fr)
*
|
2011-08-05 |
2022-11-29 |
John W. Babich |
Inhibiteurs radiomarques d'antigene membranaire specifique de la prostate
|
US10011632B2
(en)
|
2011-08-22 |
2018-07-03 |
Siemens Medical Solutions Usa, Inc. |
PSMA imaging agents
|
US9034318B2
(en)
|
2011-08-30 |
2015-05-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria
|
WO2013060793A1
(fr)
*
|
2011-10-25 |
2013-05-02 |
Technische Universität München |
Ligands bifonctionnels pour métaux radioactifs
|
WO2013070457A2
(fr)
|
2011-11-01 |
2013-05-16 |
The Johns Hopkins University |
Procédé et dispositif pour l'abrasion endoscopique
|
CN113149921A
(zh)
|
2011-11-30 |
2021-07-23 |
约翰霍普金斯大学 |
前列腺特异性膜抗原(psma)的同源多价抑制剂和异源多价抑制剂以及其用途
|
EP2800471A4
(fr)
|
2012-01-06 |
2015-11-04 |
Molecular Insight Pharm Inc |
Complexe métalliques de poly (carboxyl) amine contenant des ligands ayant une affinité pour l'anhydrase carbonique ix
|
EP2822386B1
(fr)
|
2012-02-29 |
2021-05-05 |
Purdue Research Foundation |
Ligands de liaison au récepteur alpha de folates
|
US9498546B2
(en)
|
2012-03-14 |
2016-11-22 |
The Johns Hopkins University |
Synthesis and application of novel imaging agents conjugated to DPA 713 analogs for imaging inflammation
|
WO2013166110A1
(fr)
|
2012-05-02 |
2013-11-07 |
Yale University |
Molécules de recrutement d'anticorps conjugués à un agoniste de tlr)
|
IN2014MN02492A
(fr)
|
2012-06-08 |
2015-07-17 |
Aduro Biotech |
|
DK2877599T3
(da)
|
2012-07-27 |
2020-01-20 |
Aragon Pharmaceuticals Inc |
Fremgangsmåder og sammensætninger til bestemmelse af resistens overfor androgenreceptorterapi
|
MX2015004757A
(es)
|
2012-10-16 |
2015-07-17 |
Endocyte Inc |
Conjugados de suministro de farmacos que contienen aminoacidos no naturales y metodo para usarlos.
|
US20140107316A1
(en)
|
2012-10-16 |
2014-04-17 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
US20140113322A1
(en)
|
2012-10-22 |
2014-04-24 |
The Johns Hopkins University |
Supramolecular nanobeacon imaging agents as protease sensors
|
WO2014066002A1
(fr)
|
2012-10-23 |
2014-05-01 |
The Johns Hopkins University |
Nouveaux médicaments amphiphiles à auto-assemblage et méthodes de synthèse et d'utilisation
|
CN108042811A
(zh)
|
2012-11-15 |
2018-05-18 |
恩多塞特公司 |
用于治疗由psma表达细胞引起的疾病的共轭物
|
US20140154702A1
(en)
|
2012-11-30 |
2014-06-05 |
Endocyte, Inc. |
Methods For Treating Cancer Using Combination Therapies
|
KR102002826B1
(ko)
|
2012-12-04 |
2019-07-23 |
삼성전자 주식회사 |
저장 장치, 플래시 메모리 및 저장 장치의 동작 방법
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
WO2014106208A1
(fr)
|
2012-12-28 |
2014-07-03 |
Blend Therapeutics, Inc. |
Conjugués ciblés encapsulés dans des particules et formulations correspondantes
|
HUE035739T2
(en)
|
2013-01-14 |
2018-05-28 |
Molecular Insight Pharm Inc |
Triazine-based radiopharmaceuticals and radiological imaging agents
|
EP2958596B1
(fr)
|
2013-02-15 |
2019-12-04 |
Case Western Reserve University |
Ligands de psma et utilisation de ces derniers
|
US10207005B2
(en)
|
2013-02-15 |
2019-02-19 |
Case Western Reserve University |
Photodynamic therapy composition
|
US20140249315A1
(en)
|
2013-03-01 |
2014-09-04 |
Endocyte, Inc. |
Processes for preparing tubulysins
|
US9255262B2
(en)
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
US9567402B2
(en)
|
2013-03-14 |
2017-02-14 |
The Regents Of The University Of California |
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
|
US10434194B2
(en)
|
2013-06-20 |
2019-10-08 |
Case Western Reserve University |
PSMA targeted nanobubbles for diagnostic and therapeutic applications
|
EP3019522B1
(fr)
|
2013-07-10 |
2017-12-13 |
Sutro Biopharma, Inc. |
Anticorps comprenant plusieurs résidus d'acides aminés non naturels site-spécifiques, des procédés permettant leur préparation et leurs méthodes d'utilisation
|
JP5817799B2
(ja)
|
2013-10-10 |
2015-11-18 |
ダイキン工業株式会社 |
空気調和機
|
WO2015052532A1
(fr)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Conjugués anticorps-pyrrolobenzodiazépines
|
WO2015057692A1
(fr)
|
2013-10-14 |
2015-04-23 |
The Johns Hopkins University |
Photosensibilisants ciblant l'antigène membranaire spécifique de la prostate pour thérapie photodynamique
|
US10406246B2
(en)
|
2013-10-17 |
2019-09-10 |
Deutsches Kresbsforschungszentrum |
Double-labeled probe for molecular imaging and use thereof
|
LT4095130T
(lt)
*
|
2013-10-18 |
2024-04-25 |
Novartis Ag |
Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti
|
CN105792855A
(zh)
|
2013-10-18 |
2016-07-20 |
分子制药洞察公司 |
使用spect/ct分析进行癌症分期的方法
|
US20150110814A1
(en)
|
2013-10-18 |
2015-04-23 |
Psma Development Company, Llc |
Combination therapies with psma ligand conjugates
|
SG10201803618RA
(en)
|
2013-11-14 |
2018-06-28 |
Endocyte Inc |
Compounds for positron emission tomography
|
ITAN20130219A1
(it)
|
2013-11-21 |
2015-05-22 |
Gianluca Valentini |
Farmaco anti-cancro, comprendente un radioisotopo del rame
|
AU2014351565A1
(en)
|
2013-11-25 |
2016-06-09 |
Oxford Biotherapeutics Ltd |
Antibodies anti Matriptase for the treatment of cancer
|
US9346846B1
(en)
|
2013-12-02 |
2016-05-24 |
Yale University |
Anti-cancer compounds and methods for treating cancer
|
JP6595479B2
(ja)
|
2013-12-18 |
2019-10-23 |
コーニンクレッカ フィリップス エヌ ヴェ |
心臓特性または呼吸特性に基づき睡眠除波活動をエンハンスするシステム及び方法
|
WO2015143029A1
(fr)
|
2014-03-18 |
2015-09-24 |
The Johns Hopkins University |
Système de rapporteur génétique moléculaire à base de psma
|
US10683272B2
(en)
|
2014-05-06 |
2020-06-16 |
The Johns Hopkins University |
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
|
EP2944635B1
(fr)
|
2014-05-15 |
2018-11-28 |
Council of Scientific & Industrial Research |
Conjugués de benzimidazole liés au pyrazole et leur procédé de préparation
|
US9814759B2
(en)
|
2014-07-02 |
2017-11-14 |
Cheer Global Ltd. |
Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment
|
EP3177298A4
(fr)
|
2014-08-06 |
2018-04-11 |
The Johns Hopkins University |
Procédés de traitement de la maladie inflammatoire de l'intestin à l'aide d'inhibiteurs de psma -antigène de membrane spécifique de la prostate-
|
US9988407B2
(en)
|
2014-08-06 |
2018-06-05 |
The Johns Hopkins University |
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
|
EP2993171A1
(fr)
|
2014-09-04 |
2016-03-09 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Procédé pour la production des traceurs PET spécifique PSMA
|
US10112974B2
(en)
|
2014-08-24 |
2018-10-30 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. |
Method for the production of 18F-labeled active esters and their application exemplified by the preparation of a PSMA-specific PET-tracer
|
JP6860476B2
(ja)
|
2014-08-25 |
2021-04-14 |
ザ ジョンズ ホプキンズ ユニヴァーシティー |
前立腺がん治療に関する方法及び組成物
|
CA2959726A1
(fr)
|
2014-09-08 |
2016-03-17 |
Molecular Insight Pharmaceuticals, Inc. |
Protection d'organes dans une therapie radionucleaire ciblant le psma du cancer de la prostate
|
WO2016062370A1
(fr)
|
2014-10-20 |
2016-04-28 |
Deutsches Krebsforschungszentrum |
Inhibiteurs à marquage 18f- de l'antigène membranaire spécifique de la prostate (psma), leur utilisation comme agents d'imagerie et agents pharmaceutiques pour le traitement du cancer de la prostate
|
US10736974B2
(en)
|
2014-10-22 |
2020-08-11 |
The Johns Hopkins University |
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
|
ES2832802T3
(es)
|
2014-11-21 |
2021-06-11 |
Univ Maryland |
Sistemas de administración dirigida del particulado específico de una estructura
|
KR101698654B1
(ko)
|
2014-12-24 |
2017-01-20 |
포항공과대학교 산학협력단 |
En2에 특이적으로 결합하는 dna 압타머 및 이의 용도
|
WO2016115415A1
(fr)
|
2015-01-16 |
2016-07-21 |
The Johns Hopkins University |
Promédicaments d'albumine-proaérolysine
|
US20180148480A1
(en)
|
2015-01-16 |
2018-05-31 |
The Johns Hopkins University |
Synthetic enhancement of the t-cell armamentarium as an anti-cancer therapy
|
US9808516B2
(en)
|
2015-04-13 |
2017-11-07 |
Aduro Biotech, Inc. |
Immunogenic fusion proteins for the treatment of cancer
|
CN108473957A
(zh)
|
2015-04-17 |
2018-08-31 |
诺华股份有限公司 |
改善嵌合抗原受体表达细胞的功效和扩增的方法
|
US9808538B2
(en)
|
2015-09-09 |
2017-11-07 |
On Target Laboratories, LLC |
PSMA-targeted NIR dyes and their uses
|
KR101639599B1
(ko)
|
2015-11-09 |
2016-07-14 |
서울대학교산학협력단 |
펩타이드 싸이오우레아 유도체, 이를 포함하는 방사성 동위원소 표지 화합물 및 이를 유효 성분으로 함유하는 전립선암 치료 또는 진단용 약학적 조성물
|
FR3043970B1
(fr)
|
2015-11-25 |
2019-06-21 |
Medtech Sa |
Systeme mecanique de stabilisation au sol pour vehicules a roulettes
|
US10688200B2
(en)
|
2015-12-31 |
2020-06-23 |
Five Eleven Pharma Inc. |
Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy
|
EP3510399B1
(fr)
|
2016-09-09 |
2023-03-01 |
On Target Laboratories, LLC |
Colorants nir ciblés sur psma et leurs utilisations
|
SG11201909513QA
(en)
|
2017-04-11 |
2019-11-28 |
Univ Johns Hopkins |
Prodrugs of 2-pmpa for healthy tissue protection during psma-targeted cancer imaging or radiotherapy
|
KR20200111169A
(ko)
|
2017-12-13 |
2020-09-28 |
사이언콘스 에이에스 |
납 또는 토륨 방사성핵종에 연결된 psma-타게팅 화합물을 포함하는 복합체
|
KR20200124706A
(ko)
|
2018-02-22 |
2020-11-03 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
에반스 블루 유도체의 화학적 접합체 및 전립선 암 표적화를 위한 방사선 치료 및 조영제로서의 용도
|
MX2020013804A
(es)
|
2018-06-21 |
2021-03-31 |
Regeneron Pharma |
Anticuerpos anti-psma x anti-cd28 biespecíficos y usos de estos.
|